What's new on this website
February 2010
8 February 2010
5 February 2010
- Expressions of interest for membership of the Therapeutic Goods Committee (new)
- Consultation: Requirements for the prescription medicine streamlined submission process (new)
- Updated: Advice to consumers regarding Hydroxycut products (new)
3 February 2010
2 February 2010
- New medicines safety advisory committee appointed
<http://www.health.gov.au/internet/ministers/publishing.nsf/Content/mr-yr10-mb-mb010.htm?OpenDocument>
Media release from Parliamentary Secretary for Health, Mark Butler, 2 February 2010
1 February 2010
January 2010
29 January 2010
28 January 2010
27 January 2010
- Questions & answers relating to the additional default standards legislation (updated)
- Drugs designated as orphan drugs (added PEGATRON COMBINATION THERAPY)
22 January 2010
- Public submissions: Proposed Section 7 Declaration: that products in capsule, tablet and pill form are therapeutic goods (new)
- Drugs designated as orphan drugs (added MYFORTIC)
18 January 2010
- Reductil (sibutramine) product information (new)
- Cost recovery impact statement: Regulatory arrangements for the scheduling of medicines, agricultural and veterinary chemicals and other substances (consultation)
13 January 2010
- Proposed regulatory requirements for in vitro diagnostic devices (added December 2009 presentations)
- Anticipated shortage of injectable Indomethacin (INDOCID PDA) (new)
12 January 2010
11 January 2010
- Australian Public Assessment Report (AusPAR) for prescription medicines (added Follitropin alfa (rch) and Lutropin alfa (rch) - proprietary product name: Pergoveris)